INTRODUCTION
- Gastro-oesophageal reflux (GOR) is a normal physiological process
- GORD occurs when the effect of GOR leads to symptoms severe enough to merit medical treatment
- There is very little evidence to support a causal relationship between GORD and its assumed consequences e.g. apnoeas, respiratory distress and failure to thrive, especially in preterm babies
- There is also limited evidence for use of anti-reflux medications, which should therefore be avoided. There is evidence for the association of GORD with cow’s milk protein sensitisation
RECOGNITION AND ASSESSMENT
Symptoms which could suggest GORD
- Frequent vomiting after feeds in an otherwise healthy baby
- Recurrent desaturation and/or apnoea
- Recurrent desaturations in ventilated babies [exclude bronchopulmonary dysplasia (BPD) spells]
- Chronic lung disease of prematurity may be worsened by recurrent aspiration caused by GORD
Risk factors
- Immaturity of the lower oesophageal sphincter
- Chronic relaxation of the sphincter
- Increased abdominal pressure
- Gastric distension
- Hiatus hernia
- Malrotation
- Oesophageal dysmotility
- Neurodevelopmental abnormalities
Differential diagnosis
- Suspect cow’s milk protein intolerance (CMPI) in babies who are formula milk fed or have fortifier added to maternal breast milk, and have recurrent vomiting/irritability/apnoeas despite appropriate management of GORD
INVESTIGATIONS
- 24 hr pH monitoring is of limited value in preterm babies. Consider in cases where repeated apnoea/bradycardia is resistant to other measures
- Following investigations to be considered after discussion with consultant:
- if repeated apnoea/bradycardia, consider 24 hr pulse oximetry recordings to assess extent of problem and relationship to feeding
- if apnoeas/bradycardia persist at term-equivalent, consider video fluoroscopic assessment of sucking-swallowing co-ordination and GORD
- in severe cases, referral to gastroenterology may be appropriate for consideration of upper GI endoscopy or barium swallow investigation
MANAGEMENT
Position
- Head upwards, at an angle of 30°
- Nurse baby prone or in left lateral position, if they are monitored
- Consider involvement of occupational therapy and/or developmental care team to ensure appropriate responses to stress and behavioural cues are not misinterpreted
Feeding
- For formula fed babies, try frequent low volume or continuous feeds
- Babies ≥34 weeks': consider Instant Carobel® according to manufacturer’s instructions (take care that thickened liquid does not block fine bore NGT)
- Babies >34 weeks’ gestation: if no improvement with feed thickener, consider an alginate (Gaviscon Infant®) according to manufacturer’s instructions (1 dose = half dual sachet)
- Review every 14 days
Do not give Gaviscon Infant® and Carobel® together as this will cause the milk to become too thick
Caution: Gaviscon Infant® contains 0.92 mmol of sodium per dose
Other measures
- If symptoms persist, consider other measures after discussion with consultant.
- dairy free diet for a breastfeeding mother or trial of cow’s milk protein-free formula (in artificially fed babies). If trial commenced, continue for ≥2 weeks with careful symptom monitoring
- assessment by speech and language therapy team for those with ongoing or unusual symptoms would be appropriate such as:
- poor co-ordination of suck and swallow
- longer than expected time to transition to oral feeding
- aspiration
- Babies requiring specialist formulas should be supported by local dietetic services
There is no evidence to support use of drugs in GORD
H2 receptor antagonists e.g. ranitidine may increase risk of sepsis, perforation or necrotising enterocolitis
Erythromycin may facilitate bacterial resistance and has been associated with pyloric stenosis, and is not recommended
PARENT INFORMATION
- GORD in preterm babies is common and parents can be reassured of the normality of GOR (supported by Bliss parent information https://www.bliss.org.uk/parents/about-your-baby/medical-conditions/reflux)
Date updated: 2024-01-11